Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
08/2005
08/10/2005EP1560823A1 4-substituted 1-aminocyclohexane derivatives for utilization as orl1-receptor and mu-opiate receptor ligands
08/10/2005EP1560822A1 4-imidazol-1-ylmethyl-pyrimidine derivatives as ligands for gabaa receptors
08/10/2005EP1560818A1 Non-peptide gnrh agents, pharmaceutical compositions and methods for their use
08/10/2005EP1560813A1 Novel piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
08/10/2005EP1560809A1 Cyclohexylurea derivatives
08/10/2005EP1560806A2 4-alkyl/4-alkenyl/4-alkynyl methyl/-1-arylcyclohexylamine derivatives
08/10/2005EP1560589A1 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives
08/10/2005EP1560581A1 Oromucosal formulation and process for preparing the same
08/10/2005EP1560580A1 Sulfonamides, sulfamates and sulfamides as gamma-secretase inhibitors
08/10/2005EP1560579A1 Cholesterol absorption inhibitors for the treatment of autoimmune disorders
08/10/2005EP1478637B1 Amorphous citalopram salts
08/10/2005EP1451166B1 Citric acid salt of a therapeutic compound and pharmaceutical compositions thereof
08/10/2005EP1399406B1 Novel estrogen receptor ligands and methods i
08/10/2005EP1392674B1 Furan and thiophene derivatives that activate human peroxisome proliferator activated receptors
08/10/2005EP1345946B1 Macroheterocylic compounds useful as kinase inhibitors
08/10/2005EP1339679B1 3-arylindole derivatives and their use as cb2 receptor agonists
08/10/2005EP1324760A4 Creatine ester pronutrient compounds and formulations
08/10/2005EP1292581B1 Bicyclic cyclohexylamines and their use as nmda receptor antagonists
08/10/2005EP1208103B1 Reverse-turn mimetics and methods relating thereto
08/10/2005EP1194425B1 Substituted benzimidazole
08/10/2005EP1157002B1 1,2,3,4-tetrahydro-1-naphthalenamine compounds useful in therapy
08/10/2005EP1086093B1 Tetrahydroquinoline derivatives as glycine antagonists
08/10/2005EP1069900B1 Use of reboxetine for the treatment of neuropsychiatric disorders
08/10/2005EP1042359B1 Kappa receptor opioid peptides
08/10/2005EP1009447B1 Hydroxymethyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals and method of making same
08/10/2005EP0957903B1 Diols of norbornene and norbornane compounds for treating pigmentation disorders, neurodegenerative diseases or proliferative skin disorders
08/10/2005EP0833622B1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor
08/10/2005CN1653089A Organic medicine and betacyclodextrin derivative and preparation process thereof
08/10/2005CN1653075A C-aryl glucoside SGLT2 inhibitors and method
08/10/2005CN1653068A Novel diazabicyclic biaryl derivatives
08/10/2005CN1653067A Carbazole derivatives and their use as NPY5 receptor antagonists
08/10/2005CN1653062A (imidazol-1-yl-methyl)-pyridazine as NMDA receptor blocker
08/10/2005CN1653059A Macrocyclic compounds useful as pharmaceuticals
08/10/2005CN1653055A Thiazolidine-4-one derivative, method for preparing the same, and pharmaceutical composition containing the same
08/10/2005CN1653054A Benzoxazine derivatives as 5-HT6 modulators and uses thereof
08/10/2005CN1653052A Novel imidazole compounds, method for preparing same and use thereof as medicines
08/10/2005CN1653050A Opioid and opioid-like compounds and uses thereof
08/10/2005CN1653046A 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
08/10/2005CN1653044A Pentafluorosulfanylbenzoylguanidines, processes for their preparation, their use as medicaments or diagnostic aids, and medicaments comprising them
08/10/2005CN1653042A Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
08/10/2005CN1653040A HIF hydroxylase inhibitors
08/10/2005CN1653036A Amino acids with affinity for the alpha-2-delta-protein
08/10/2005CN1653032A Substituted phenylalkanoic acid derivatives and use thereof
08/10/2005CN1653025A NK1 antagonists
08/10/2005CN1652820A Methods of treatment using CTLA-4 antibodies
08/10/2005CN1652810A Immunosuppressant compounds, methods and uses related thereto
08/10/2005CN1652808A Hepatoprotective activity of 2'-p-hydroxybenzoylmussaenosidic
08/10/2005CN1652803A Medicine for prevention of and treatment for amyloidosis
08/10/2005CN1652794A Neuroprotective spirostenol pharmaceutical compositions
08/10/2005CN1652791A Synergistic enhancement of cognitive ability
08/10/2005CN1652787A Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists
08/10/2005CN1652784A Substituted quinolone carboxylic acids, their derivatives, site of action, and uses thereof
08/10/2005CN1652782A Nicotinamide derivatives useful as PDE4 inhibitors
08/10/2005CN1652779A Treatment of chemokine mediated diseases
08/10/2005CN1652777A Combination of organic compounds
08/10/2005CN1652773A Substantially pure solid form of the enol tautomer of 3-indolylpyruvic acid for use in the treatment of central nervous system disturbances
08/10/2005CN1652772A (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1, 3-dione: methods of using and compositions thereof
08/10/2005CN1652770A Use of statins and other immunomodulatory agents in the treatment of autoimmune disease
08/10/2005CN1652769A Phosphate prodrugs of fluorooxindoles
08/10/2005CN1652767A Adduct of topiramate and tramadol hydrochloride and uses thereof
08/10/2005CN1652754A Tasted masked veterinary solid compositions
08/10/2005CN1652751A A method to improve surface properties of pharmaceutical tablets
08/10/2005CN1652687A Choline-silicic acid complex with osmolytes and divalent trace elements
08/10/2005CN1651455A Pseudo portulaca oleracea saponin compound, total sapon in and its application in medicine
08/10/2005CN1651453A Japanese polygala saponin kind compound and aglucon, total saponin and total aglucon and its application in medicine
08/10/2005CN1651430A Synthesis method of saijiabin, its racemate and S-configuration, and preparation method of its amorphous powder
08/10/2005CN1651075A Therapeutic application of cone shell toxin SO3
08/10/2005CN1651054A Chinese medicine for treating brain disease
08/10/2005CN1651028A Medicinal composition having synergistic action
08/10/2005CN1651008A Chinese medicine for treating blood vessel nature feeble-mindedness
08/10/2005CN1650966A Chinese medicinal injection liquid for giving up drug
08/10/2005CN1650907A Zhogkang pill
08/10/2005CN1650906A New type tobacco abstaining cigarette
08/10/2005CN1650902A Extracting medicament possessing blood supplement spirit quiet boasting and calming functrous from pure Chinese medical preparation and method thereof
08/10/2005CN1650895A Method of extracting medicamout having memory strengthening function from natural plant compound preparation
08/10/2005CN1650891A Medicinal composition posssessing synergistic action
08/10/2005CN1650886A Biological product for nourishing stomach, protecting liver, dispelling liquor effect and its manufacturing method
08/10/2005CN1650876A New use of ginseng saponin-Re medicine and its preparation method
08/10/2005CN1214114C Activatable recombinant neurotoxins
08/10/2005CN1214026C Indol-3-yl derivatives
08/10/2005CN1214025C Sodium channel modulators derived from 2-piperidylimidazoles
08/10/2005CN1214022C Vitamin D analogues
08/10/2005CN1214017C 四唑衍生物 Tetrazole derivatives
08/10/2005CN1214008C Therapeutic biaryl derivatives
08/10/2005CN1214006C Novel vitamin D derivatives with cyclopropyl rings in lateral chains, its production method and intermediate and utilization thereof for producing medicaments
08/10/2005CN1213999C Aliphatic amino carboxylic and amino phosphonic acids, amino nitriles and amino tetrazoles as cellular rescue agents
08/10/2005CN1213753C Composition alleviating pain, containing a non-napcotic and an analgesia enhancer
08/10/2005CN1213744C Remedies
08/10/2005CN1213742C Pharmaceutical control of inflammation
08/10/2005CN1213737C Oral controlled release formulations
08/10/2005CN1213733C Method of preparing stable suspension of insoluble microparticles
08/09/2005US6927317 Modulating ramp activity
08/09/2005US6927303 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
08/09/2005US6927234 possessing anti-cancer activity, anti-inflammatory activity, anti-obesity activity, and/or hair growth promotion activity
08/09/2005US6927232 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles
08/09/2005US6927231 and stress-related degenerative processes associated with aging or diseases such as cancer, neurodegenerative disease or dysregulation of redox-regulated physiological processes, indicated by prooxidative shift in plasma thiol/disulfide redox state
08/09/2005US6927230 Triazole derivatives
08/09/2005US6927228 Biphenyl compounds usefuf in treatment of human and veterinary medicines such as dermatology, cardivovascular diseases, immune diseases or diseases associated with lipid metabolisms, or in cosmetic formulation
08/09/2005US6927224 Anticancer agents; osteoporosis
08/09/2005US6927222 Compounds
1 ... 952 953 954 955 956 957 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 ... 1833